13 results
8-K
EX-1.1
VTGN
VistaGen Therapeutics Inc
4 Oct 23
Entry into a Material Definitive Agreement
4:07pm
SC 13G
EX-1
Commodore Capital LP
9 Aug 23
Vistagen Therapeutics / COMMODORE CAPITAL ownership change
4:15pm
SC 13G
EX-1
VTGN
VistaGen Therapeutics Inc
14 Apr 22
VistaGen Therapeutics / COMMODORE CAPITAL ownership change
4:42pm
8-K
EX-1.1
VTGN
VistaGen Therapeutics Inc
14 May 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-1.1
VTGN
VistaGen Therapeutics Inc
22 Dec 20
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
4:17pm
8-K
EX-1.1
07xtn731fa45zcmh8
5 Aug 20
VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock
9:56pm
8-K
EX-1.1
jsodx ar2yyyb6
4 Mar 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-1.1
vz3qxv4gx 9d7qmv
13 Dec 17
VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-1.1
or6tk 5ncjkof39zp
31 Aug 17
VistaGen Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-1.1
tj8647q s41jp7a
16 May 16
VistaGen Announces Nasdaq Listing and Pricing of $10.0 Million Public Offering
12:00am
SC 13D
EX-1
nepmd mw0lo4qxoj
14 Jun 11
VistaGen Therapeutics / CATO HOLDING ownership change
12:00am
- Prev
- 1
- Next